Celltrion Chief Enjoys Biggest Gain in Stock Value in H1
SEOUL, July 9 (Korea Bizwire) — The chief of the pharmaceutical group Celltrion saw the value of his stock holdings rise the most among the heads of South Korea’s major business groups in the first half, data showed Thursday. Seo Jung-jin held 5.85 trillion won (US$4.9 billion) worth of listed shares in group flagship Celltrion [...]